Georgia Local Democracy Jeopardized - Congress Report

The Congress of Local and Regional Authorities of the Council of Europe issued a report finding local democracy in Georgia to be in jeopardy, citing rapid democratic backsliding, high polarisation, one-party rule over local authorities, and lack of follow-up on past recommendations. The Congress debated findings from a fact-finding visit conducted September 24-25, 2025, and deplored irregularities in the October 4, 2025 local elections including widespread boycotts, electoral law changes, and intimidation of opposition voices.

Ukrainian local and national authorities unite for reconstruction

Ukrainian local and national authorities unite for reconstruction

Crystalline Nitrogen-Containing Heterocyclic Compound Patent Application

The European Patent Office published patent application EP4480952A1 filed by Shanghai Pharmaceuticals Holding Co., Ltd. for a crystalline form of a nitrogen-containing heterocyclic compound with anti-cancer applications. The application covers the compound's chemical structure, preparation methods, and therapeutic uses under IPC classification C07D471/04.

Novel ACC inhibitors

The European Patent Office published patent EP4562017A1 for novel ACC (Acetyl-CoA Carboxylase) inhibitors filed by Pfizer Inc. The patent claims priority based on application EP4562017 and covers compounds classified under C07D 513/10 with therapeutic applications in dermatological (A61P 17/10) and anti-inflammatory (A61P 29/00) uses. The patent is validated across 27 European Designated States including major markets.

Stereoselective Technologies for Chiral Compounds Patent

The European Patent Office published patent application EP4476202A1 by Wave Life Sciences Ltd. on March 25, 2026. The patent covers stereoselective technologies for the synthesis of chiral compounds, including various IPC classifications in organic chemistry (C07D, C07F, C07H). The application names nine inventors and designates 37 European states.

Prodrug kit for multi-pronged chemotherapy

The European Patent Office published patent application EP4551565A1 for a prodrug kit designed for multi-pronged chemotherapy, filed by Alex Zounek. The invention covers pharmaceutical compositions including heterocyclic compounds classified under C07D and A61K, with applications in cancer treatment (A61P 35/00). The patent designates all current EPO member states.

Cereblon E3 Ubiquitin Ligase Inhibitor Patent

The European Patent Office published patent application EP4471033A1 for Gan & Lee Pharmaceuticals' Cereblon E3 ubiquitin ligase inhibitor compounds. The patent covers heterocyclic compositions (C07D derivatives) with applications in cancer treatment. Publication occurred March 25, 2026.

PROTEIN DEGRADERS AND USES THEREOF

The European Patent Office published Kymera Therapeutics' patent application EP4499149A1 for protein degrader compounds and their therapeutic uses. The patent covers chemical compositions under IPC classifications C07D 401/14, C07D 409/04, C07D 487/04 and their applications in treating diseases. This is a standard patent publication granting exclusive rights across 39 designated European member states.

Nucleoside LINE-1 Inhibitors for Cancer and Neurodegenerative Diseases

The European Patent Office published patent application EP4499106A2 for nucleoside LINE-1 inhibitors filed by Transposon Therapeutics, Inc. The patent covers novel therapeutic compounds targeting LINE-1 retrotransposons with applications in cancer treatment and neurodegenerative diseases. Publication includes international classifications spanning organic chemistry (C07D), nucleosides (C07H), and pharmaceutical preparations (A61K).

Thiazole Derivatives as Tau Aggregation Inhibitors for Alzheimer's Treatment

The European Patent Office published patent application EP4590666A1 for TauRx Therapeutics Management Ltd., covering thiazole derivatives as tau aggregation inhibitors for treating Alzheimer's disease (A61P 25/28). The patent names eight inventors including Claude Michel Wischik and protects compounds classified under C07D 277/56 and related thiazole derivative formulations (A61K 31/426). The designation covers all 31 European Patent Convention contracting states.